Alexion Pharmaceuticals - Company & Market Research Reports

Home /
Companies /
Alexion Pharmaceuticals

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 49
Central Nervous System Drugs 38
Immune Disorders Drugs 24
Biopharmaceuticals 22
Endocrine and Metabolic Disorders Drugs 21
Biotechnology 19
Hematological Drugs 19
Oncology Drugs 13
Pharmaceuticals 13
Liver and Kidney Disorders Drugs 12
Allergy and Immunology 10
Genomics 10
Musculoskeletal Disorders Drugs 10
Cardiovascular Drugs 9
Drugs by Therapeutic Area 8
Enzymes 8
Optical Disorders Drugs 6
Infusions and Injectables 6
Company Reports 5
Drug Delivery 5
Hematology 5
Therapeutic Area 4
Clinical Trials 4
Diagnostics 4
Needles and Syringes 4
Infectious Diseases Drugs 3
Proteomics 3
Laboratory Equipment 3
Pharmaceutical Manufacturing 3
Pharmaceutical Intermediates 2
In Vitro Diagnostics 2
Optical 2
Vaccines 2
Respiratory Drugs 2
Biosimilars and Biosuperiors 2
Dermatological Drugs 2
Allergy Drugs 2
Addiction Disorders Drugs 1
Urology and Nephrology 1
Pharmacoeconomics 1
Leukemia Drugs 1
Lymphoma Drugs 1
Colon Cancer Drugs 1
Bioinformatics 1
Cardiovascular Devices 1
Stents 1
Infectious Disease Testing 1
Analgesics 1
Cough and Cold Drugs 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Medical Devices 1
Biomarkers 1
Gastrointestinal Drugs 1
Nanomedicine 1
Gastroenterology 1
Oncology 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

271 Results (Page 2 of 14)
- Relevance
  Sort by

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

 Report
May 2023
391 Pages
Global

From

€4689EUR$4,799USD£3,914GBP

Plasma Protease C1-Inhibitor Treatment - Global Strategic Business Report

 Report
November 2024
196 Pages
Global

From

€4836EUR$4,950USD£4,038GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

 Report
September 2024
750 Pages
Global

From

€3903EUR$3,995USD£3,259GBP

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
325 Pages
Global

From

€4689EUR$4,799USD£3,914GBP

Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2024

 Report
September 2024
550 Pages
Global

From

€3903EUR$3,995USD£3,259GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

 Report
April 2020
536 Pages
Global

From

€4787EUR$4,899USD£3,996GBP

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

 Report
October 2023
68 Pages
Global

From

€6834EUR$6,995USD£5,706GBP

Antibody Drugs: Technologies and Global Markets

 Report
September 2024
156 Pages
Global

From

€4543EUR$4,650USD£3,793GBP

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

 Report
March 2023
182 Pages
Global

From

€1855EUR$1,899USD£1,549GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4885EUR$5,000USD£4,078GBP

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

 Report
January 2020
410 Pages
Global

From

€4787EUR$4,899USD£3,996GBP

Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026

 Report
August 2021
159 Pages
Global

From

€2687EUR$2,750USD£2,243GBP

€5374EUR$5,500USD£4,486GBP

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
696 Pages
Global

From

€2443EUR$2,500USD£2,039GBP

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

 Report
May 2019
385 Pages
Global

From

€4396EUR$4,499USD£3,670GBP

Lupus Nephritis - Market Insight, Epidemiology and Market Forecast - 2032

 Report
January 2024
169 Pages
Global

From

€5130EUR$5,250USD£4,282GBP

€7328EUR$7,500USD£6,118GBP

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

 Report
February 2022
84 Pages
Global

From

€1269EUR$1,299USD£1,060GBP

Royalty Rates in Pharmaceutical and Biotechnology Deals

 Report
August 2024
500 Pages
Global

From

€3903EUR$3,995USD£3,259GBP

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
432 Pages
Global

From

€2443EUR$2,500USD£2,039GBP

Vitiligo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
124 Pages
Global

From

€1954EUR$2,000USD£1,631GBP

Autoimmune Collaboration and Licensing Deals 2016-2024

 Report
October 2024
500 Pages +
Global

From

€3903EUR$3,995USD£3,259GBP

271 Results (Page 2 of 14)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.